All 18F-FDG PET/CT imaging was performed using Discovery VCT scanners and Discovery STe scanners (GE Medical Systems, Milwaukee, WI, USA) at Yeungnam University Medical Center and Samsung Medical Center, respectively. PET/CT scans were acquired after a single FDG injection. Patients fasted for 6 hours before the 18F-FDG injection (serum glucose level <140 mg/dL). FDG dose was corrected for body mass index, and approximately 5.5 MBq/kg of FDG was administered intravenously. Uptake of 18F-FDG on PET/CT was visually interpreted as positive or negative by comparing the foci of increased metabolic activity between normal surrounding tissues and tumor tissue (12 (link)).